Dr. James D. Young, MD
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Virginia Commonwealth University, School of Medicine (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,565
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Virginia Commonwealth University, School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
VA license 0101054461
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sentara Leigh Hospital Norfolk, VA
- Sentara Virginia Beach General Hospital Virginia Beach, VA
- Sentara Princess Anne Hospital Virginia Beach, VA
- Chesapeake General Hospital Chesapeake, VA
- Sentara Albemarle Medical Center Elizabeth City, NC
Medical groups
- Urology of Virginia, PLLC (72 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,565
- Services billed
- 7,215
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Automated urinalysis test | 1,103 | 801 |
| Ultrasound measurement of bladder capacity after voiding | 616 | 475 |
| Insertion of needle into vein for collection of blood sample | 552 | 526 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 549 | 64 |
| Established patient office or other outpatient visit, 30-39 minutes | 511 | 425 |
| Bacterial colony count, urine | 369 | 220 |
| Psa (prostate specific antigen) measurement, total | 322 | 263 |
| Established patient office or other outpatient visit, 20-29 minutes | 310 | 287 |
| Bacterial urine culture | 262 | 163 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 223 | 151 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Virginia Beach, VA | 351 |
| Finasteride Other prescribers in Virginia Beach, VA | 217 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Virginia Beach, VA | 103 |
| Cephalexin Other prescribers in Virginia Beach, VA | 75 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Virginia Beach, VA | 70 |
| Myrbetriq (mirabegron) Other prescribers in Virginia Beach, VA | 63 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Virginia Beach, VA | 49 |
| Levofloxacin Other prescribers in Virginia Beach, VA | 44 |
| Potassium Citrate Er (potassium citrate) Other prescribers in Virginia Beach, VA | 38 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Virginia Beach, VA | 37 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 5 payments worth $216 in total to this clinician.
| Janssen Biotech, Inc. | $89.04 |
|---|---|
| Procept Biorobotics Corporation | $54.62 |
| AstraZeneca Pharmaceuticals LP | $35.06 |
| C. R. Bard, Inc. & Subsidiaries | $21.56 |
| Cook Medical LLC | $16.04 |
| Food and Beverage | $181 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,882 in research payments for these studies, mostly to the institutions running them.
- Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH
Teleflex LLC · Status unknown · NCT04987892
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.